FDA Approves Levacetylleucine for Ataxia-Telangiectasia
FDA Approves Levacetylleucine for Ataxia-Telangiectasia NeurologyLive
Regulatory Approvals
FDA Approves Imlunestrant in Combination With Abemaciclib for ER-Positive, HER2-Negative, ESR1-Mutated Advanced or Metastatic Breast Cancer
FDA Approves Imlunestrant in Combination With Abemaciclib for ER-Positive, HER2-Negative, ESR1-Mutated Advanced or Metastatic Breast Cancer The ASCO Post
FDA Approves Finerenone for CKD Associated With Type 1 Diabetes
FDA Approves Finerenone for CKD Associated With Type 1 Diabetes Patient Care Online
FDA Clears sNDA for Taletrectinib With Updated DOR Data in ROS1+ NSCLC
FDA Clears sNDA for Taletrectinib With Updated DOR Data in ROS1+ NSCLC OncLive
FDA Approves First Gene Therapy for Sanfilippo Syndrome Type A
FDA Approves First Gene Therapy for Sanfilippo Syndrome Type A CGTLive®